Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class ITerminatedD-0184-2023

Drug recall · February 1, 2023

Vancomycin Hydrochloride for Injection recall

Why: Presence of Particulate Matter: Glass particulate matter detected in injectable.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose Fliptop Vial, 10 vials per carton, Rx only, Distributed by: Hospira, Inc., Lake Forest, IL 60045. NDC Vial 0409-3515-11; NDC Carton 0409-3515-01

Lots / codes

Lot: 33045BA, EXP 1SEP2023

Quantity
89,700 vials
Company
Pfizer Inc., New York, NY
Distribution
USA nationwide and Puerto Rico
Initiated
December 22, 2022 · Voluntary: Firm initiated
Classified
January 25, 2023
Reported
February 1, 2023
Ended
August 7, 2024
How notified
Press Release

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Vancomycin

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.